EPICTRIAL.COM KEYWORD DENSITY CHECKER

Total words: 2209 | 2-word phrases: 558 | 3-word phrases: 650 | 4-word phrases: 701

PAGE INFO

Title Try to keep the title under 60 characters (25 characters)
EPIC Study: Official Site
Description Try to keep the meta description between 50 - 160 characters (137 characters)
Learn more about the EPIC (Evaluation of Pimobendan In dogs with Cardiomegaly) Study, the largest veterinary cardiology study in history.
Keywords Meta keywords are not recommended anymore (0 characters)
H1 H1 tag on the page (23 characters)
The results are EPIC1,2

ONE WORD PHRASES 300 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1the3712.33%
2study3110.33%
3epic289.33%
4of258.33%
5in217.00%
6dogs155.00%
7to124.00%
8and113.67%
9disease103.33%
10heart93.00%

TWO WORD PHRASES 558 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1epic study234.12%
2the epic142.51%
3dogs with61.08%
4in dogs61.08%
5myxomatous mitral61.08%
6mitral valve61.08%
7study publication50.90%
8valve disease50.90%
9respiratory rate50.90%
10composite primary40.72%
11rate rr40.72%
12in the40.72%
135 years40.72%
14thumbnail image30.54%
15125 years30.54%
16study mean30.54%
17of the30.54%
18stage b230.54%
19preclinical mmvd30.54%
20with preclinical30.54%

THREE WORD PHRASES 650 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1the epic study101.54%
2myxomatous mitral valve60.92%
3mitral valve disease50.77%
4in dogs with50.77%
5epic study publication40.62%
6j vet intern30.46%
7respiratory rate rr30.46%
8vet intern med30.46%
9pimobendan in dogs30.46%
10the pimobendan group20.31%
11about the epic20.31%
12in the pimobendan20.31%
13dogs with stage20.31%
14with stage b220.31%
15stage b2 myxomatous20.31%
16b2 myxomatous mitral20.31%
17change within 120.31%
18quality of life20.31%
19classification of canine20.31%
20life without chf20.31%
21of canine heart20.31%
22and managing preclinical20.31%
23preclinical myxomatous mitral20.31%
24with preclinical myxomatous20.31%
25days in the20.31%
26ingelheim vetmedica gmbh20.31%
27composite primary endpoint20.31%
28of the epic20.31%
29to composite primary20.31%
30time to composite20.31%

FOUR WORD PHRASES 701 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1myxomatous mitral valve disease50.71%
2j vet intern med30.43%
3in the pimobendan group20.29%
4and managing preclinical mmvd20.29%
5diagnosing and managing preclinical20.29%
6häggström j et al20.29%
7variables in dogs with20.29%
8boswood a gordon sg20.29%
9dogs with stage b220.29%
10time to composite primary20.29%
11in dogs with preclinical20.29%
12pimobendan in dogs with20.29%
13epic study j vet20.29%
14study j vet intern20.29%
15of pimobendan in dogs20.29%
16classification of canine heart20.29%
17the epic study mean20.29%
18about the epic study20.29%
19with stage b2 myxomatous20.29%
20b2 myxomatous mitral valve20.29%
213rd epic study publication20.29%
22with preclinical myxomatous mitral20.29%
23significant change within 120.29%
24preclinical myxomatous mitral valve20.29%
25stage b2 myxomatous mitral20.29%
26for all small to10.14%
27over 5 years years10.14%
28countries over 5 years10.14%
29randomised clinical study in10.14%
30being 125 years fifteen10.14%
31countries countries over 510.14%
32lifespan for all small10.14%
33dogs being 125 years10.14%
34all small to mediumsized10.14%
35veterinary cardiology history1 3610.14%
36cardiology history1 36 centres10.14%
37placebocontrolled doubleblinded placebocontrolled 1110.14%
38history1 36 centres centres10.14%
39doubleblinded placebocontrolled doubleblinded placebocontrolled10.14%
4036 centres centres 36010.14%

EXTERNAL LINKS

# URL Whois Check